Lesions included in the analysis | Histopathological confirmation | |
---|---|---|
(n = 597) | (n = 147) | |
Tumor type a,b | ||
Lung cancer | 104 | 40 |
Head and neck cancer | 61 | 32 |
Gastrointestinal cancerc | 129 | 24 |
Breast cancer | 60 | 6 |
Lymphoma | 125 | 20 |
Melanoma | 26 | 10 |
Multiple melanoma | 32 | 3 |
Otherd | 60 | 12 |
Clinical question b | ||
Diagnosis | 22 | 10 |
Staging | 20 | 11 |
Restaginge | 33 | 18 |
Response to chemotherapy | 58 | 6 |
Response to radiotherapy | 18 | 6 |
Post-surgery evaluation | 11 | 0 |
Surveillance | 40 | 22 |
Site of disease b | ||
Neck | 93 | 33 |
Thorax | 110 | 49 |
Abdomen | 220 | 45 |
Skeleton-bone marrow | 174 | 20 |
Lymph nodesf | 198 | 32 |